Biotech NewsPepGen (PEPG) s Poised to Disrupt Rare Disease Therapy BioTech Health XJune 15, 2025 PepGen Inc. (NASDAQ:PEPG) is a U.S.-based clinical-stage biotechnology company at the forefront of genetic medicine, focused on developing… 0 Shares 0 0 0 0 0 0 0